Not Signed In - Main Topic Area
All Topic Areas
1 - 7 of 7
News
1 - 5 of 41 more >>
- FDA Approves 18-Month Shelf Life For TAXUS(R) Stent System
MedicalNewsToday - Sat, 20 Jan 2007 08:00 EST
- FDA Approves 18-Month Shelf Life For TAXUS(R) Stent System
MedicalNewsToday - Fri, 19 Jan 2007 08:00 EST
- Study In European Heart Journal Favors TAXUS(TM) Over Cypher(TM) And Bare-Metal-Stents In Diabetic Patients
MedicalNewsToday - Sat, 20 Jan 2007 11:00 EST
- Study In European Heart Journal Favors TAXUS(R) Stent Over Cypher(R) Stent And Bare-Metal Stents In Diabetic Patients
MedicalNewsToday - Sat, 13 Jan 2007 08:00 EST
- Avastin(reg) Is First Medicine To Extend Survival Beyond One Year In Patients With Previously Untreated Non-small Cell Lung Cancer
MedicalNewsToday - Sun, 17 Dec 2006 04:00 EST
Clinical Trials
1 - 5 of 700 more >>
- Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
ClinicalTrials.gov Identifier: NCT00004057 - Active, not recruiting
Cancer
- Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00003644 - Active, not recruiting
ovarian epithelial cancer
- Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients with Advanced Cancer
ClinicalTrials.gov Identifier: NCT00100139 - Active, not recruiting
Neoplasm
- Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma
ClinicalTrials.gov Identifier: NCT00193531 - Active, not recruiting
Neuroendocrine Carcinoma
- Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women with Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00102622 - Active, not recruiting
Ovarian Cancer
email this page
print this page
bookmark this page
feedback on this page
